晚期结果作为癌症查试验中死亡率的替代品:系统性审查和元分析
Matejka Rebolj1, Adam R Brentnall1, Julia Geppert2
1Queen Mary University of London, London, United Kingdom.
概括
在癌症查试验中,晚期癌症发病率显示为癌症查试验中死亡率的替代物. 需要进一步的研究来证实它在不同癌症类型和疾病中的可靠性.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 流行病学 流行病学
背景情况:
- 晚期癌症发病率是查试验中癌症特异性死亡率的替代结果.
- 之前的元分析就晚期癌症终点的适用性得出了不一致的结论.
- 本研究系统地审查了查试验中晚期癌症发病率和死亡率结果之间的关联.
研究的目的:
- 研究癌症查对晚期癌症发病率和癌症特异性死亡率的影响之间的相关性.
- 评估晚期癌症发病率的潜力,作为癌症查试验中的替代结果.
主要方法:
- 57项癌症查试验的系统综述和元分析 (61项试验对手臂的比较).
- 对查对晚期癌症发病率和癌症特异性死亡率的影响之间的相关性分析.
- 评估死亡率影响估计是否属于晚期发病率估计的置信区间.
主要成果:
- 在所有癌症中,在晚期发病率和死亡率结果之间发现了0.69 (95% CI:0.47-0.84) 的综合相关性.
- 具体相关性:肠癌为0.58,乳腺癌为0.79和肺癌为0.91.
- 死亡率效应估计在92%的比较中处于晚期发病率置信区间内.
结论:
- 晚期癌症发病率显示潜在的作为癌症查试验的关键结果.
- 需要进一步的研究来确定最佳的测量时间,并针对未研究过的癌症类型进行外推.
- 晚期癌症发病率可能无法准确预测死亡率的条件需要澄清.
更多相关视频
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Kaplan-Meier Approach
272
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
272
Actuarial Approach
137
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
137
Assumptions of Survival Analysis
199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
Comparing the Survival Analysis of Two or More Groups
291
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
291
Life Tables
199
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
199


